Home Articles List Article Information
Alexandria Dental Journal
Journal Archive
Volume Volume 50 (2025)
Volume Volume 49 (2024)
Volume Volume 48 (2023)
Volume Volume 47 (2022)
Volume Volume 46 (2021)
Volume Volume 45 (2020)
Volume Volume 44 (2019)
Volume Volume 43 (2018)
Volume Volume 42 (2017)
Volume Volume 41 (2016)
Volume Volume 40 (2015)
Younis, R. (2020). A METHOD FOR DIGITAL QUANTIFICATION OF EOSINOPHILS INFILTRATE IN ORAL SQUAMOUS CELL CARCINOMA. Alexandria Dental Journal, 45(2), 74-78. doi: 10.21608/adjalexu.2020.88441
Rania Younis. "A METHOD FOR DIGITAL QUANTIFICATION OF EOSINOPHILS INFILTRATE IN ORAL SQUAMOUS CELL CARCINOMA". Alexandria Dental Journal, 45, 2, 2020, 74-78. doi: 10.21608/adjalexu.2020.88441
Younis, R. (2020). 'A METHOD FOR DIGITAL QUANTIFICATION OF EOSINOPHILS INFILTRATE IN ORAL SQUAMOUS CELL CARCINOMA', Alexandria Dental Journal, 45(2), pp. 74-78. doi: 10.21608/adjalexu.2020.88441
Younis, R. A METHOD FOR DIGITAL QUANTIFICATION OF EOSINOPHILS INFILTRATE IN ORAL SQUAMOUS CELL CARCINOMA. Alexandria Dental Journal, 2020; 45(2): 74-78. doi: 10.21608/adjalexu.2020.88441

A METHOD FOR DIGITAL QUANTIFICATION OF EOSINOPHILS INFILTRATE IN ORAL SQUAMOUS CELL CARCINOMA

Article 12, Volume 45, Issue 2, August 2020, Page 74-78  XML PDF (322.26 K)
Document Type: Original Article
DOI: 10.21608/adjalexu.2020.88441
View on SCiNiTO View on SCiNiTO
Author
Rania Younis email 1, 2, 3
1Lecturer, Department of Oral Pathology, Faculty of Dentistry, Alexandria University, Egypt
2Assistant professor of oral pathology, Department of Oncology and Diagnostic Sciences, School of Dentistry, University of Maryland Baltimore
3Associate member, University of Maryland Greenebaum Comprehensive Cancer Center, Tumor immunology and immunotherapy division.
Abstract
Introduction:The recent advances in tumor immunotherapy triggered more attention towards analysis of tumor inflammation. Oral squamous cell carcinoma (OSCC) is malignancy that can be therapeutically challenging and resistant to treatment. Further investigation of the inflammatory profile in OSCC can enhance our understanding of the disease and hence patient response to immunotherapy. Eosinophils are suggested to play a significant role in tumor progression and have been described to be associated with advanced stage malignancies of several tumor subtypes. 
Objective: Here we wanted to assess a methodology to quantitatively measure eosinophils infiltrate in OSCC. 
Material and methods: Eosinophils infiltrate was analyzed in formalin fixed paraffin embedded tissue (FFPE) microarray cores of 30 oral squamous cell carcinomas (OSCC), and 10 normal oral epithelium controls. Digital analysis using the auto fluorescence of eosinophils accentuated by Alexa Fluor 488 stain, in FFPE tissue sections; we used Cytation 5 machine and Gen 5 software, to digitally quantify the extent of eosinophils infiltrate in OSCC.
Results: Out of the inflamed OSCC examined sections with heavy inflammatory infiltrate rich in eosinophils, RBCs, neutrophils and monocytes, eosinophils were readily detected, and digitally quantified after staining with Alexa Fluor 488. The tumor cores showed eosinophils infiltrate in the peri-tumoral stroma of 26 (87%) of the 30 examined OSCC
Conclusion: This study highlights the importance of assessment of the type and extent of inflammatory cells infiltrate as well as its digital quantification. It provides a novel quantification method of eosinophils that opens avenues to study the correlation between eosinophils infiltrate and tumor prognosis.
Keywords
digital; quantification; eosinophils; oral squamous cell carcinoma; autofluorescence
Main Subjects
Oral pathology
References
  1. Seiwert TY, Burtness B, Mehra R, Weiss J, Berger R, Eder JP, et al. Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial. Lancet Oncol2016 Jul;17(7):956-65.
  2. Mirza AH, Thomas G, Ottensmeier CH, King EV. Importance of the immune system in head and neck cancer. Head Neck2019 Feb 28.
  3. Kagedal A, Rydberg Millrud C, Hayry V, Kumlien Georen S, Lidegran M, Munck-Wikland E, et al. Oropharyngeal squamous cell carcinoma induces an innate systemic inflammation, affected by the size of the tumour and the lymph node spread. Clin Otolaryngol2018 Apr 21.
  4. Piva MR, LB DES, Martins-Filho PR, Nonaka CF, T DESS, ES DESA, Piva D. Role of inflammation in oral carcinogenesis (Part II): CD8, FOXP3, TNF-alpha, TGFbeta and NF-kappaB expression. Oncol Lett2013 Jun;5(6):1909-14.
  5. Chow LQ, Haddad R, Gupta S, Mahipal A, Mehra R, Tahara M, et al. Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion Cohort. J Clin Oncol2016 Sep 19.
  6. Pak AS, Wright MA, Matthews JP, Collins SL, Petruzzelli GJ, Young MR. Mechanisms of immune suppression in patients with head and neck cancer: presence of CD34(+) cells which suppress immune functions within cancers that secrete granulocytemacrophage colony-stimulating factor. Clin Cancer Res1995 Jan;1(1):95-103.
  7. Ravin KA, Loy M. The Eosinophil in Infection. Clin Rev Allergy Immunol2016 Apr;50(2):214-27.
  8. Wen T, Rothenberg ME. The Regulatory Function of Eosinophils. Microbiol Spectr2016 Oct;4(5).
  9. Weller PF, Spencer LA. Functions of tissue-resident eosinophils. Nat Rev Immunol2017 Dec;17(12):746-60.
  10. De Paz D, Chang KP, Kao HK, Lao WW, Huang YC, Chang YL, et al. Clinical Implications of TumorAssociated Tissue Eosinophilia in Tongue Squamous Cell Carcinoma. Laryngoscope2018 Aug 10.
  11. Sassler AM, McClatchey KD, Wolf GT, Fisher SG. Eosinophilic infiltration in advanced laryngeal squamous cell carcinoma. Veterans Administration Laryngeal Cooperative Study Group. Laryngoscope1995 Apr;105(4 Pt 1):413-6.
  12. Ono Y, Fujii M, Kameyama K, Otani Y, Sakurai Y, Kanzaki J. Expression of matrix metalloproteinase-1 mRNA related to eosinophilia and interleukin-5 gene expression in head and neck tumour tissue. Virchows Arch1997 Nov;431(5):305-10.
  13. Joshi PS, Kaijkar MS. A histochemical study of tissue eosinophilia in oral squamous cell carcinoma using Congo red staining. Dent Res J (Isfahan)2013 Nov;10(6):784-9.
  14. Ye L, Wang H, Li H, Liu H, Lv T, Song Y, et al. Eosinophil peroxidase over-expression predicts the clinical outcome of patients with primary lung adenocarcinoma. J Cancer2019;10(4):1032-8.
  15. Gao J, He Y, Wu L. [The clinical analysis of eosinophil infiltration in human squamous cell carcinoma of buccal mucosa]. Hua Xi Kou Qiang Yi Xue Za Zhi1997 Aug;15(3):228-9, 32.
  16. Ethier C, Lacy P, Davoine F. Identification of human eosinophils in whole blood by flow cytometry. Methods Mol Biol2014;1178:81-92.
  17. Msaouel P, Massarelli E. Immune Checkpoint Therapy in Head and Neck Cancers. Cancer J2016 MarApr;22(2):108-16.
  18. Hamdan D, Leboeuf C, Le Foll C, Bousquet G, Janin A. Re-exploring immune-related side effects of docetaxel in an observational study: Blood hypereosinophilia. Cancer Med2019 Mar 10.
  19. Kay AB. The eosinophil in infection diseases. J Infect Dis1974 May;129(5):606-13.
  20. Simon D, Simon HU. Therapeutic strategies for eosinophilic dermatoses. Curr Opin Pharmacol2019 Feb 8;46:29-33.
  21. Kruckel A, Moreira A, Frohlich W, Schuler G, Heinzerling L. Eosinophil-cationic protein - a novel liquid prognostic biomarker in melanoma. BMC Cancer2019 Mar 7;19(1):207.
  22. Caruso AA, Costigliola F, Salzano J, Del Prete S, Marasco D, Imperatore C, et al. Nasal and systemic eosinophilia associated with solid intestinal tumors, a case report and review of the literature. Ann Ital Chir2019 Mar 4;8.
  23. Tadbir AA, Ashraf MJ, Sardari Y. Prognostic significance of stromal eosinophilic infiltration in oral squamous cell carcinoma. J Craniofac Surg2009 Mar;20(2):287-9.
  24. Suzuki K, Inokuchi A, Miyazaki J, Kuratomi Y, Izuhara K. Relationship between squamous cell carcinoma antigen and the clinical severity of allergic rhinitis caused by Dermatophagoides farinae and Japanese cedar pollen. Ann Otol Rhinol Laryngol2010 Jan;119(1):22-6.
  25. Saxena S, Singh A, Singh P, Sundaragiri KS, Sankhla B, Bhargava A. Evaluating the Role of Immunological Cells (Tissue Eosinophils and Mast Cells) in Progression of Oral Squamous Cell Carcinoma. Mymensingh Med J2018 Apr;27(2):382-8.
  26. Debta P, Debta FM, Chaudhary M, Bussari S. Evaluation of myeloid cells (tumor-associated tissue eosinophils and mast cells) infiltration in different grades of oral squamous cell carcinoma. Indian J Med Paediatr Oncol2016 Jul-Sep;37(3):158-67.
  27. Jain S, Phulari RG, Rathore R, Shah AK, Sancheti S. Quantitative assessment of tumor-associated tissue eosinophilia and mast cells in tumor proper and lymph nodes of oral squamous cell carcinoma. J Oral Maxillofac Pathol2018 May-Aug;22(2):227-33.
  28. Vaibhav SL, Priya PL, Sonam CK, Supriya K, Garima Y, Sabeer S, et al. Evaluation of Tumor-associated Tissue Eosinophilia in Different Stages of Oral Squamous Cell Carcinoma using Special Stains: An in vitro Histopathological Study. J Contemp Dent Pract2018 May 1;19(5):579-86.
  29. Peurala E, Tuominen M, Loyttyniemi E, Syrjanen S, Rautava J. Eosinophilia is a favorable prognostic marker for oral cavity and lip squamous cell carcinoma. APMIS2018 Mar;126(3):201-7.
  30. Martinelli-Klay CP, Lombardi T, Mendis B, Soares EG, Salvado F, Courvoisier DS, et al. Tissue eosinophilia in oral intraepithelial neoplasia as a probable indicator of invasion. Oral Dis2018 Mar;24(1-2):103-8.
Statistics
Article View: 352
PDF Download: 546